The University of Cape Town’s Clinical Trials Unit (UCT CTU) is led by its overarching Principal Investigator Professor Linda-Gail Bekker. The UCT CTU sits under the Faculty of Health Sciences institute of Infectious Disease and Molecular Medicine. None of the work we do is possible without the support of the 300 plus staff members we employ whilst currently coordinating around 10 clinical trials.
The UCT CTU implements research that is at the forefront in resolving internationally important research questions in infectious diseases. Our robust systems, governance structures and clinical trial expertise helps us deliver multi Network complex international clinical research studies.
The UCT CTU objectives is to efficiently, excellently and maximally further the Global Prevention and Therapeutic Clinical Sciences in HIV, TB, Hepatitis and related infections and conditions. We also aim to meet the Scientific Goals of NIAID and its Networks through world class clinical research implementation whilst building on and expanding clinical and scientific capacity locally and regionally. We aim to achieve in partnership with our local communities’ implementation of research that is locally relevant and internationally prioritised.
We conduct and implement scientific research agendas for the Division of AIDs (DAIDs) Networks.
Our research helps to improve healthcare in the South Africa and around the world.